OPALEYE MANAGEMENT INC. Inhibrx Biosciences, Inc. Transaction History

OPALEYE MANAGEMENT INC. portfolio value:

$5.25M
portfolio value

OPALEYE MANAGEMENT INC. quarter portfolio value change:

+58.15%
quarter

Inhibrx Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -50.39% -297.3K shares -1.44M $17.95 292.7K
Q2 2022 share Increase 0.00% 590K shares 6.69M $11.35 590K